Cargando…

Predictive significance of preoperative CT findings for suboptimal cytoreduction in advanced ovarian cancer: a meta-analysis

BACKGROUND: Computed tomography (CT) has been extensively used in predicting suboptimal cytoreduction (SCR) in advanced ovarian cancer (OC). However, disagreements remain in literatures on the predictive value of CT findings for SCR. This meta-analysis was designed to determine the ability of eight...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ting Wen Yi, Nie, Dan, Gou, Jin Hai, Li, Zheng Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053262/ https://www.ncbi.nlm.nih.gov/pubmed/30038518 http://dx.doi.org/10.2147/CMAR.S166658

Ejemplares similares

Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
por: Llueca, Antoni, et al.
Publicado: (2018)

Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer
por: Llueca, Antoni, et al.
Publicado: (2021)

The Significance of Preoperative Computed Tomography for Predicting Optimal Cytoreduction in Advanced Ovarian Cancer
por: Stachs, Angrit, et al.
Publicado: (2020)

Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer
por: Eo, Wankyu, et al.
Publicado: (2016)

Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2023)

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer
por: Chong, Gun Oh., et al.
Publicado: (2019)

Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
por: Mousavi, Azam-Sadat, et al.
Publicado: (2010)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
por: Koirala, Pratistha, et al.
Publicado: (2020)

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial
por: Ferrandina, G, et al.
Publicado: (2009)

Minilaparotomy, Cyfra21-1, and Other Predicting Factors for Suboptimal Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer: A Pilot Study
por: Nantasupha, Chalaithorn, et al.
Publicado: (2022)

Laparoscopic Cytoreduction for Primary Advanced Ovarian Cancer
por: Fanning, James, et al.
Publicado: (2010)

Role of aggressive surgical cytoreduction in advanced ovarian cancer
por: Chang, Suk-Joon, et al.
Publicado: (2015)

Predicting incomplete cytoreduction in patients with advanced ovarian cancer
por: Egger, Eva K., et al.
Publicado: (2022)

Prognostic Significance of Preoperative NLR, MLR, and PLR Values in Predicting the Outcome of Primary Cytoreductive Surgery in Serous Epithelial Ovarian Cancer
por: Kovács, Anna Rebeka, et al.
Publicado: (2023)

The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma
por: Nunes, Rafael Leite, et al.
Publicado: (2023)

Prognostic SIGNIFICANCE of Cytoreductive Therapy of Ovarian Cancer – eastern Croatia experience
por: Topolovec, Zlatko, et al.
Publicado: (2019)

Preoperative Serum CA-125 Level As a Predictor for The Extent of Cytoreduction in Patients with Advanced Stage Epithelial Ovarian Cancer
por: Merlo, Sebastjan, et al.
Publicado: (2021)

Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery
por: Jeong, Soo Young, et al.
Publicado: (2020)

Prognostic significance of preoperative CT findings in patients with advanced gastric cancer who underwent curative gastrectomy
por: Park, Chae Jung, et al.
Publicado: (2018)

Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis
por: Bartels, Helena C., et al.
Publicado: (2019)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer
por: Kim, Na Young, et al.
Publicado: (2021)

In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery
por: Kaban, Alpaslan, et al.
Publicado: (2019)

When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place?
por: Martinek, Igor E., et al.
Publicado: (2010)

Prognostic value of preoperative serological biomarkers in patients undergoing cytoreductive surgery for ovarian cancer peritoneal metastases
por: Khaled, Charif, et al.
Publicado: (2023)

The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis
por: Ding, Ting, et al.
Publicado: (2021)

Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer
por: Yang, Hee Chul, et al.
Publicado: (2021)

Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer
por: Kim, Myeong-Seon, et al.
Publicado: (2022)

CT Enterography for Preoperative Evaluation of Peritoneal Carcinomatosis Index in Advanced Ovarian Cancer
por: Delgado-Barriga, Katty, et al.
Publicado: (2022)

Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancer
por: Yu Zang, Rong, et al.
Publicado: (2006)

Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
por: Feng, Li-yuan, et al.
Publicado: (2020)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
por: Zhang, Guyu, et al.
Publicado: (2019)

Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis
por: Llueca, Maria, et al.
Publicado: (2023)

Improved prognosis for recurrent epithelial ovarian cancer by early diagnosis and 125I seeds implantation during suboptimal secondary cytoreductive surgery: a case report and literature review
por: Xiao, Lin, et al.
Publicado: (2020)

Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies
por: Tewari, Krishnansu S.
Publicado: (2016)

Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma
por: Ye, Shuang, et al.
Publicado: (2017)

Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models
por: Laios, Alexandros, et al.
Publicado: (2020)

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer
por: McNamara, Blair, et al.
Publicado: (2021)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
por: Dhiman, Pravesh, et al.
Publicado: (2022)

Reconstruction of the diaphragm with autologous fascia lata during cytoreduction in patients with advanced ovarian cancer
por: Kanao, Hiroyuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0bo2162pn0irrum5leqts6dn0f